EXHIBIT 11 BIOGEN, INC. and SUBSIDIARIES Computation of Earnings Per Share (unaudited) (in thousands, except per share amounts) Three months ended March 31, 1995 1994 Primary earnings per share Weighted average number of shares outstanding. . . . . . . . . . . . . 33,166 32,402 Shares deemed outstanding from the assumed exercise of stock options and warrants. . . . . . . . . . . . 2,311 3,339 -------- -------- Total . . . . . . . . . . . . . . . . . . . 35,477 35,741 ======== ======== Net income. . . . . . . . . . . . . . . . . $ 2,834 $ 11,229 ======== ======== Primary earnings per share of common stock . . . . . . . . . . $ 0.08 $ 0.31 ======== ======== Fully diluted earnings per share (a) Weighted average number of shares outstanding. . . . . . . . . . . . 33,166 32,402 Shares deemed outstanding from the assumed exercise of stock options and warrants. . . . . . . . . . . 2,406 3,339 -------- -------- Total . . . . . . . . . . . . . . . . . . . . 35,572 35,741 ======== ======== Net income . . . . . . . . . . . . . . . . $ 2,834 $ 11,229 ======== ======== Fully diluted earnings per share of common stock . . . . . . . . . $ 0.08 $ 0.31 ======== ======== (a) This calculation is submitted in accordance with Regulation S-K item 601 (b) (11) although not required by Footnote 2 to Paragraph 14 of APB Opinion No. 15 because it results in dilution of less than 3%.